Phase 2 Oligometastatic Prostate Cancer trials recruiting now

All Oligometastatic Prostate Cancer trials, every phase

Phase 2 Oligometastatic Prostate Cancer trials

• Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
  NCT05915442 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 1 location
• Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
  NCT06387056 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
  NCT05560659 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Maximal Tumor Eradication for Oligometastatic Prostate Cancer
  NCT06972511 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: Male · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.